Stemedica

CORE COMPETENCIES

Stemedica currently dedicates its resources to four primary areas neurology, cardiology, ophthalmology and dermatology. As part of this focus, we provide products to institutions engaged in preclinical and clinical trial for the following indications:

Hear about how Stemedica is applying its stem cell technology to support clinical research across a number of different areas.
 

Neurology

  • Stroke
  • Alzheimer's
  • Parkinson's
  • Spinal Cord Injury

Cardiology

  • Post-myocardial infarction
  • Cardiomyopathy

Ophthalmology

  • Macular degeneration
  • Retinitis Pigmentosa
  • Diabetic retinopathy

Dermatology

  • Burns
  • Chronic wounds
  • Scars

Stemedica continues to explore other opportunities in which our strategic and distribution partners express an interest in advancing a medical indication where there is a great need.